HCG

Why Researchers Study HCG

Human chorionic gonadotropin (HCG) is a glycoprotein gonadotropin that acts as a long-acting analog of luteinising hormone. Its beta subunit is close enough to LH’s to bind the same receptor, but its carbohydrate structure makes it clear far more slowly — so a single dose produces hours of steady LH-like signalling where endogenous LH would deliver short pulses. That property makes HCG the reference probe for the gonadal end of the hypothalamic-pituitary-gonadal (HPG) axis.

Where kisspeptin acts at the very top of the axis (hypothalamic GnRH neurons), HCG bypasses the hypothalamus and pituitary entirely and stimulates the testis directly. Researchers use the two at opposite ends of the same axis.

Mechanism of Action

HCG binds the LH/CG receptor (LHCGR) on Leydig cells. Receptor activation couples through Gs to adenylyl cyclase, raising cAMP and activating protein kinase A. PKA drives StAR-mediated transport of cholesterol into the mitochondrion — the rate-limiting step of steroidogenesis — followed by enzymatic conversion through pregnenolone to testosterone.

The key endpoint in most HCG literature is not serum testosterone but intratesticular testosterone (ITT), which sits far above serum levels and is what spermatogenesis actually requires. Coviello et al. (2005) showed that low-dose HCG maintains ITT in men whose gonadotropins were experimentally suppressed by exogenous testosterone, and Roth et al. (2010) mapped a dose-dependent ITT response down to doses as low as 15–125 IU every other day.

Research Context

Investigational literature uses HCG in three main settings: as a stimulation test for Leydig-cell reserve (measuring the testosterone response to a single dose), as a maintenance stimulus in gonadotropin-suppression models where endogenous LH is absent, and in fertility research on spermatogenesis. Its long receptor occupancy is the reason protocols dose every other day or a few times weekly rather than daily.

Handling & Reconstitution

Supplied as a lyophilised powder in a 5000 IU vial. Reconstitute with bacteriostatic water, added slowly against the vial wall rather than directly onto the pellet, and swirl gently instead of shaking — HCG is a glycoprotein and vigorous agitation can denature it. Store lyophilised vials refrigerated; once reconstituted, keep at 2–8 °C and protected from light. A 5000 IU vial reconstituted with 2ml of bacteriostatic water yields 2500 IU/ml, so a 250 IU research dose corresponds to 0.1ml (10 units on a U-100 insulin syringe).